Get started
Author

Koichi Hirata

Observed name: K. Hirata
Observed institution: Dokkyo Medical University
ORCID: 0000-0002-6492-4734
Observed ORCID: 0000-0002-6492-4734
OpenAlex ID: A5124206116
A Real‐World Study of CGRP Monoclonal Antibodies for Migraine: Long‐Term Effectiveness and Treatment Adherence
2026 · Keisuke Suzuki, Shiho Suzuki, et al. · European Journal of Neurology · 9
Interictal thermal pain hypersensitivity and central sensitization in migraine patients: a case–control study using quantitative sensory testing
2026 · Keisuke Suzuki, Shiho Suzuki, et al. · Head & Face Medicine · 3
Real-world achievement of higher standards for migraine prevention with CGRP monoclonal antibodies
2026 · Keisuke Suzuki, Shiho Suzuki, et al. · Cephalalgia · 1
Delphi consensus on the real-world application of the updated diagnostic and treatment guidelines for migraine in Asia Pacific
2026 · Charles Hua Chiang Siow, Shengyuan Yu, et al. · Frontiers in Neurology
PDF
Clinical influence of restless legs syndrome in migraine patients: a 12-year single-center longitudinal study
2026 · K. Suzuki, S. Suzuki, et al. · Sleep Medicine
Calcitonin gene-related peptide monoclonal antibodies improve symptoms of restless legs syndrome in patients with migraine
2026 · M. Kashiwagi, S. Kobayashi, et al. · Sleep Medicine
A rare genetic variant in the cleavage site of prepro-orexin confers susceptibility to idiopathic hypersomnia
2026 · T. Miyagawa, S. Tanaka, et al. · Sleep Medicine
Impact of sleep problems and central sensitization in migraine patients
2026 · K. Matsubayashi, S. Kobayashi, et al. · Sleep Medicine
Works count: 8
Citation count: 13
H-index: 2
I10-index:
Year
Topic
Type